Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment.
OBJECTIVE
A clear association among snoring, sleep apnea, and increased risk of stroke has been shown by previous studies. However, the possible role played by sleep apnea in the pathogenesis of cerebrovascular disease is subject to debate. To evaluate the influence of hemodynamic changes caused by obstructive sleep apnea syndrome (OSAS), we investigated cerebrovascular reactivity to hypercapnia in patients with OSAS.


METHODS
The study was performed at baseline and after 1 night and 1 month of nasal continuous positive airway pressure (n-CPAP) therapy, with patients in the waking state (8:00 to 8:30 AM and 5:30 to 6:00 PM) with transcranial Doppler ultrasonography. Cerebrovascular reactivity was calculated with the breath-holding index (BHI).


RESULTS
In the baseline condition, compared with normal subjects, patients with OSAS showed significantly lower BHI values in both the morning (0.57 versus 1.40, p < 0.0001) and the afternoon (1.0 versus 1.51, p < 0.0001). Cerebrovascular reactivity was significantly higher in the afternoon than it was in the morning in both patients (p < 0.0001) and controls (p < 0.05). In patients, the BHI returned to normal values, comparable with those of control subjects, after both 1 night and 1 month of n-CPAP therapy.


CONCLUSIONS
These findings suggest an association between OSAS and diminished cerebral vasodilator reserve. This condition may be related to the increased susceptibility to cerebral ischemia in patients with OSAS, particularly evident in the early morning.
Diomedi
M
M
Neurological Clinic, S. Eugenio Hospital, Tor Vergata University of Rome, Italy.
Placidi
F
F
Cupini
L M
LM
Bernardi
G
G
Silvestrini
M
M
D000328:Adult; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000032:analysis; D002560:Cerebrovascular Circulation; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D017286:Polysomnography; D011175:Positive-Pressure Respiration; D012119:Respiration; D012891:Sleep Apnea Syndromes / Q000503:physiopathology* / Q000628:therapy*; D012894:Sleep Stages
D002245:Carbon Dioxide